v3.25.2
Interim Statement of Changes in Shareholders' Deficit - USD ($)
Common Stock [Member]
Maius Pharmaceutical Co. Ltd [Member]
Common Stock [Member]
Common Stock [Member]
DT Cloud Acquisition Corporation [Member]
Additional Paid-in Capital [Member]
Maius Pharmaceutical Co. Ltd [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
DT Cloud Acquisition Corporation [Member]
Subscription Receivables [Member]
Maius Pharmaceutical Co. Ltd [Member]
Subscription Receivables [Member]
AOCI Attributable to Parent [Member]
Maius Pharmaceutical Co. Ltd [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Maius Pharmaceutical Co. Ltd [Member]
Retained Earnings [Member]
Retained Earnings [Member]
DT Cloud Acquisition Corporation [Member]
Maius Pharmaceutical Co. Ltd [Member]
Total
DT Cloud Acquisition Corporation [Member]
Balance at Sep. 30, 2022 $ 11,667     $ 6,099,664     $ (10,000)   $ (188,266)   $ (5,477,540)     $ 435,525    
Balance, shares at Sep. 30, 2022 11,667                              
Foreign currency translation adjustment           23,243       23,243    
Sale of units in initial public offering, net of offering costs $ 1,236     3,013,967     (2,969,091)         46,112    
Sale of units in initial public offering, net of offering costs, shares 1,236                              
Share-based compensation $ 824     1,959,450     (824)             1,959,450    
Share-based compensation, shares 824                              
Net income               (4,344,768)     (4,344,768)    
Foreign currency translation adjustment                           23,243    
Balance at Sep. 30, 2023 $ 13,727     11,074,192     (2,969,955)   (165,023)   (9,822,308)     (1,869,367)    
Balance, shares at Sep. 30, 2023 13,727                              
Balance at Dec. 31, 2022     $ 173     $ 24,827             $ (81,326)     $ (56,326)
Balance, shares at Dec. 31, 2022     1,725,000                          
Net income                     (87,271)     (87,271)
Balance at Dec. 31, 2023     $ 173     24,827             (168,597)     (143,597)
Balance, shares at Dec. 31, 2023     1,725,000                          
Balance at Sep. 30, 2023 $ 13,727     11,074,192     (2,969,955)   (165,023)   (9,822,308)     (1,869,367)    
Balance, shares at Sep. 30, 2023 13,727                              
Foreign currency translation adjustment           (23,449)       (23,449)    
Share-based compensation                    
Net income                   (367,192)     (367,192)    
Issuance of share capital         30,781         30,781    
Foreign currency translation adjustment                           (23,449)    
Balance at Mar. 31, 2024 $ 13,727   $ 206 11,074,192   (2,939,174)   (188,472)   (10,189,500)   (1,422,284) (2,229,227)   (1,422,078)
Balance, shares at Mar. 31, 2024 13,727   2,063,000                          
Balance at Sep. 30, 2023 $ 13,727     11,074,192     (2,969,955)   (165,023)   (9,822,308)     (1,869,367)    
Balance, shares at Sep. 30, 2023 13,727                              
Foreign currency translation adjustment             (55,230)       (55,230)    
Sale of units in initial public offering, net of offering costs         30,776         30,776    
Net income             (629,176)     (629,176) [1]    
Foreign currency translation adjustment                           (55,230)    
Balance at Sep. 30, 2024 $ 13,727     11,074,192     (2,939,179)   (220,253)   (10,451,484)     (2,522,997)    
Balance, shares at Sep. 30, 2024 13,727                              
Balance at Dec. 31, 2023     $ 173     24,827             (168,597)     (143,597)
Balance, shares at Dec. 31, 2023     1,725,000                          
Sale of units in initial public offering, net of offering costs     $ 690     66,023,204                 66,023,894
Sale of units in initial public offering, net of offering costs, shares     6,900,000                          
Net income                     43,875     43,875
Sale of units to the founder in private placement     $ 23     2,344,977                 2,345,000
Sale of units to the founder in private placement, shares     234,500                          
Issuance of representative shares     $ 10     (10)                
Issuance of representative shares, shares     103,500                          
Initial classification of ordinary shares subject to possible redemption     $ (690)     (68,013,596)                 (68,014,286)
Initial classification of ordinary shares subject to possible redemption, shares     (6,900,000)                          
Allocation of offering costs to ordinary shares subject to possible redemption         2,933,590                 2,933,590
Accretion of carrying value to redemption value         (3,312,992)             (951,312)     (4,264,304)
Subsequent remeasurement of ordinary shares subject to redemption                     (346,250)     (346,250)
Balance at Mar. 31, 2024 $ 13,727   $ 206 11,074,192   (2,939,174)   (188,472)   (10,189,500)   (1,422,284) (2,229,227)   (1,422,078)
Balance, shares at Mar. 31, 2024 13,727   2,063,000                          
Balance at Dec. 31, 2023     $ 173     24,827             (168,597)     (143,597)
Balance, shares at Dec. 31, 2023     1,725,000                          
Net income                               872,741
Extension funds attributable to common stock subject to redemption                              
Remeasurement of ordinary shares subject to possible redemption                               (1,253,578)
Balance at Jun. 30, 2024     $ 206                 (1,500,746)     (1,500,540)
Balance, shares at Jun. 30, 2024     2,063,000                          
Balance at Dec. 31, 2023     $ 173     24,827             (168,597)     (143,597)
Balance, shares at Dec. 31, 2023     1,725,000                          
Sale of units in initial public offering, net of offering costs     $ 690     66,023,204                 66,023,894
Sale of units in initial public offering, net of offering costs, shares     6,900,000                          
Net income                     2,265,806     2,265,806
Sale of units to the founder in private placement     $ 23     2,344,977                 2,345,000
Sale of units to the founder in private placement, shares     234,500                          
Issuance of representative shares     $ 10     (10)                
Issuance of representative shares, shares     103,500                          
Initial classification of ordinary shares subject to possible redemption     $ (690)     (68,013,596)                 (68,014,286)
Initial classification of ordinary shares subject to possible redemption, shares     (6,900,000)                          
Allocation of offering costs to ordinary shares subject to possible redemption         2,933,590                 2,933,590
Accretion of carrying value to redemption value         (3,312,992)             (951,312)     (4,264,304)
Subsequent remeasurement of ordinary shares subject to redemption                     (3,000,071)     (3,000,071)
Balance at Dec. 31, 2024     $ 206                 (1,854,174)     (1,853,968)
Balance, shares at Dec. 31, 2024     2,063,000                          
Balance at Mar. 31, 2024 $ 13,727   $ 206 11,074,192   (2,939,174)   (188,472)   (10,189,500)   (1,422,284) (2,229,227)   (1,422,078)
Balance, shares at Mar. 31, 2024 13,727   2,063,000                          
Net income                     828,866     828,866
Subsequent remeasurement of ordinary shares subject to redemption                     (907,328)     (907,328)
Balance at Jun. 30, 2024     $ 206                 (1,500,746)     (1,500,540)
Balance, shares at Jun. 30, 2024     2,063,000                          
Balance at Sep. 30, 2024 $ 13,727     11,074,192     (2,939,179)   (220,253)   (10,451,484)     (2,522,997)    
Balance, shares at Sep. 30, 2024 13,727                              
Foreign currency translation adjustment                 63,708         63,708    
Net income                   (780,080)     (780,080)    
Issuance of share capital $ 892     2,086,210                   2,087,102    
Issuance of share capital, shares 892                              
Foreign currency translation adjustment                           (63,708)    
Balance at Mar. 31, 2025 $ 14,619   $ 206 13,160,402   (2,939,179)   (156,545)   (11,231,564)   (2,500,384) (1,152,267)   (2,500,178)
Balance, shares at Mar. 31, 2025 14,619   2,063,000                          
Balance at Oct. 03, 2024                        
Balance, shares at Oct. 03, 2024                              
Sale of units in initial public offering, net of offering costs   $ 0     (0)                  
Sale of units in initial public offering, net of offering costs, shares   1                            
Net income                   (5,984)     (5,984)  
Foreign currency translation adjustment                              
Balance at Nov. 30, 2024   $ 0     (0)         (5,984)     (5,984)  
Balance, shares at Nov. 30, 2024   1                            
Share-based compensation                    
Net income                     (28,545)     (28,545)  
Issuance of share capital                    
Foreign currency translation adjustment             1       1  
Balance at May. 31, 2025   $ 0     $ (0)       $ 1   $ (34,529)     $ (34,528)  
Balance, shares at May. 31, 2025   1                            
Balance at Dec. 31, 2024     $ 206                 (1,854,174)     (1,853,968)
Balance, shares at Dec. 31, 2024     2,063,000                          
Net income                     452,085     452,085
Extension funds attributable to common stock subject to redemption                     (357,949)     (357,949)
Remeasurement of ordinary shares subject to possible redemption                     (740,346)     (740,346)
Balance at Mar. 31, 2025 $ 14,619   $ 206 13,160,402   (2,939,179)   (156,545)   (11,231,564)   (2,500,384) (1,152,267)   (2,500,178)
Balance, shares at Mar. 31, 2025 14,619   2,063,000                          
Balance at Dec. 31, 2024     $ 206                 (1,854,174)     (1,853,968)
Balance, shares at Dec. 31, 2024     2,063,000                          
Net income                               686,742
Extension funds attributable to common stock subject to redemption                               (559,091)
Remeasurement of ordinary shares subject to possible redemption                               (1,244,127)
Balance at Jun. 30, 2025     $ 206                 (2,970,650)     (2,970,444)
Balance, shares at Jun. 30, 2025     2,063,000                          
Balance at Mar. 31, 2025 $ 14,619   $ 206 $ 13,160,402   $ (2,939,179)   $ (156,545)   $ (11,231,564)   (2,500,384) $ (1,152,267)   (2,500,178)
Balance, shares at Mar. 31, 2025 14,619   2,063,000                          
Net income                     234,657     234,657
Extension funds attributable to common stock subject to redemption                     (201,142)     (201,142)
Remeasurement of ordinary shares subject to possible redemption                     (503,781)     (503,781)
Balance at Jun. 30, 2025     $ 206                 $ (2,970,650)     $ (2,970,444)
Balance, shares at Jun. 30, 2025     2,063,000                          
[1] There are no effects on total revenue and total net income.